1. Ovarian carcinoma. Advances in diagnosis, staging and treatment;Averette;Cancer,1990
2. Cyclophosphamide and Cisplatin compared with paclitaxel and Cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N Engl J Med,1996
3. Increased nephrotoxicity of combination taxol and Cisplatin chemotherapy in gynecologic cancers compared to Cisplatin alone;Merouani;Am J Nephrol,1997
4. Taxol is active in platinum-resistant endometrial adenocarcinoma;Woo;Am J Clin Oncol,1996
5. Ning, J, T, Czerska, E, M, Casamento, J, Porter, C, Medica, J, Zabbo, A, Cohen, S, I, Stein, B, S, Effects of taxol and power frequency electromagnetic fields exposure on human prostate cancer cellsin vitro., U.S. Department of Energy, San Antonio, TX, November, 1996